Novo Holdings A/S’s Praxis Precision Medicines PRAX Stock Holding History

Novo Holdings A/S’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,667	Closed	-$2.55M	–	56
2022 Q1	$2.55M	Hold	16,667	–	–	0.13%	51
2021 Q4	$4.92M	Hold	16,667	–	–	0.23%	45
2021 Q3	$4.62M	Sell	16,667 -44,030	-73%	-$11.9M	0.24%	44
2021 Q2	$16.6M	Sell	60,697 -102,108	-63%	-$36.6M	0.74%	29
2021 Q1	$80M	Hold	162,805	–	–	3.3%	12
2020 Q4	$134M	Buy	+162,805	New	+$95M	5.76%	5

Other funds holding PRAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Novo Holdings A/S's PRAX Position: Q2 2022 in Review

Novo Holdings A/S sold out of Praxis Precision Medicines (PRAX) in Q2 2022, closing a stake of 16,667 shares — an estimated $2.55M sold.

Novo Holdings A/S first reported a position in PRAX in Q4 2020 and held it in 6 quarters. The position peaked at $134M in Q4 2020. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2022.

Novo Holdings A/S reported no remaining Praxis Precision Medicines position as of Q2 2022 after selling out during the quarter.
Novo Holdings A/S sold 16,667 Praxis Precision Medicines shares in Q2 2022, an estimated $2.55M.
Novo Holdings A/S first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 6 quarters.
Novo Holdings A/S's Praxis Precision Medicines position peaked at $134M in Q4 2020.
95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2022.

Based on Novo Holdings A/S's 13F filing for Q2 2022, filed 15 Aug 2022.